Pharmacokinetics and Safety of DWJ1451 in Healthy Adults

• Status: Enrolling by invitation
• Trial end date: 2021-04-02
• Target enrollment: 0
• Participant gender: All

Summary

Amlodipine, olmesartan, total ezetimibe, rosuvastatin AUCt, Cmax

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Daewoong Pharmaceutical Co. LTD.

Criteria

Inclusion Criteria:

• Age 19 to 55 years

• Healthy Adult

Exclusion Criteria:

• Non-Healthy